{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:43:35Z","timestamp":1778694215652,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,21]]},"DOI":"10.7759\/cureus.74171","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T18:45:12Z","timestamp":1732214712000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Different Beta Blockers in Reducing Mortality in Heart-Failure Patients"],"prefix":"10.7759","author":[{"given":"Salman Habib","family":"Roghani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dr Sanaullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aatika","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqar","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Qamber Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marriam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasnain","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Effectiveness and safety assessment of calcium channel blockers compared to beta blockers in patients with angina: an observational study","volume":"37","author":"Abidi S","year":"2024","unstructured":"Abidi S, Saeed Khan S, Naeem S, et al.. Effectiveness and safety assessment of calcium channel blockers compared to beta blockers in patients with angina: an observational study. Pak J Pharm Sci. 2024, 37:639-49.","journal-title":"Pak J Pharm Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102734","article-title":"The place of beta-adrenergic receptor blockers in the treatment of arterial hypertension: From bench-to-bedside","volume":"49","author":"Avagimyan A","year":"2024","unstructured":"Avagimyan A, Kajaia N, Gabunia L, et al.. The place of beta-adrenergic receptor blockers in the treatment of arterial hypertension: From bench-to-bedside. Curr Probl Cardiol. 2024, 49:102734. 10.1016\/j.cpcardiol.2024.102734","journal-title":"Curr Probl Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-024-02478-w","article-title":"\u03b2-adrenergic blockade attenuates adverse adipose tissue responses after burn","volume":"102","author":"Bieerkehazhi S","year":"2024","unstructured":"Bieerkehazhi S, Abdullahi A, Khalaf F, et al.. \u03b2-adrenergic blockade attenuates adverse adipose tissue responses after burn. J Mol Med (Berl). 2024, 102:1245-54. 10.1007\/s00109-024-02478-w","journal-title":"J Mol Med (Berl)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.53738\/REVMED.2024.20.886.1594","article-title":"Beta-blockers and hypertension : an old actor returns to the stage (Article in French)","volume":"20","author":"Castiglione L","year":"2024","unstructured":"Castiglione L, Rampini S, Cozzo D, Ogna A, Forni Ogna V. Beta-blockers and hypertension : an old actor returns to the stage (Article in French). Rev Med Suisse. 2024, 20:1594-7. 10.53738\/REVMED.2024.20.886.1594","journal-title":"Rev Med Suisse"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202400725RR","article-title":"The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders","volume":"38","author":"Cavalu S","year":"2024","unstructured":"Cavalu S, Saber S, Amer AE, Hamad RS, Abdel-Reheim MA, Elmorsy EA, Abdelhamid AM. The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders. FASEB J. 2024, 38:e23813. 10.1096\/fj.202400725RR","journal-title":"FASEB J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2019.04.014","article-title":"Role of beta-blockers in cardiovascular disease in 2019","volume":"72","author":"Mart\u00ednez-Milla J","year":"2019","unstructured":"Mart\u00ednez-Milla J, Raposeiras-Roub\u00edn S, Pascual-Figal DA, Ib\u00e1\u00f1ez B. Role of beta-blockers in cardiovascular disease in 2019. Rev Esp Cardiol. 2019, 72:844-52. 10.1016\/j.rec.2019.04.014","journal-title":"Rev Esp Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-024-04188-0","article-title":"Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention","volume":"24","author":"Dai Z","year":"2024","unstructured":"Dai Z, Nishihata Y, Urayama KY, Komiyama N. Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention. BMC Cardiovasc Disord. 2024, 24:511. 10.1186\/s12872-024-04188-0","journal-title":"BMC Cardiovasc Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158058","article-title":"Beta-blockers as an immunologic and autonomic manipulator in critically ill patients: a review of the recent literature","volume":"25","author":"Eraky AM","year":"2024","unstructured":"Eraky AM, Yerramalla Y, Khan A, et al.. Beta-blockers as an immunologic and autonomic manipulator in critically ill patients: a review of the recent literature. Int J Mol Sci. 2024, 25:10.3390\/ijms25158058","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102669","article-title":"Practice patterns of rate control in atrial fibrillation and clinical outcomes from a nationwide cohort","volume":"49","author":"Frick W","year":"2024","unstructured":"Frick W, Zhang Z, Rogers L, Rojulpote C, Lin CJ. Practice patterns of rate control in atrial fibrillation and clinical outcomes from a nationwide cohort. Curr Probl Cardiol. 2024, 49:102669. 10.1016\/j.cpcardiol.2024.102669","journal-title":"Curr Probl Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03094-4","article-title":"Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial","volume":"30","author":"Gill SK","year":"2024","unstructured":"Gill SK, Barsky A, Guan X, et al.. Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial. Nat Med. 2024, 30:2030-6. 10.1038\/s41591-024-03094-4","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2024.07.011","article-title":"\u03b2-adrenoceptor blockade can augment the torsadogenic action of risperidone","volume":"156","author":"Goto A","year":"2024","unstructured":"Goto A, Kambayashi R, Izumi-Nakaseko H, Takei Y, Sugiyama A. \u03b2-adrenoceptor blockade can augment the torsadogenic action of risperidone. J Pharmacol Sci. 2024, 156:134-41. 10.1016\/j.jphs.2024.07.011","journal-title":"J Pharmacol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2024.04.018","article-title":"Maintenance of beta-blockers and cardiac surgery-related outcomes: a prospective propensity-matched multicentre analysis","volume":"133","author":"Guinot PG","year":"2024","unstructured":"Guinot PG, Fischer MO, Nguyen M, Berthoud V, Decros JB, Besch G, Bouhemad B. Maintenance of beta-blockers and cardiac surgery-related outcomes: a prospective propensity-matched multicentre analysis. Br J Anaesth. 2024, 133:288-95. 10.1016\/j.bja.2024.04.018","journal-title":"Br J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.069375","article-title":"Response by Henriksen et al regarding article, \"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE trial\"","volume":"149","author":"Henriksen PA","year":"2024","unstructured":"Henriksen PA, Hall P, Lang NN. Response by Henriksen et al regarding article, \"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE trial\". Circulation. 2024, 149:e1221-2. 10.1161\/CIRCULATIONAHA.124.069375","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000779","article-title":"Propranolol attenuates the establishment of conditioned context aversions: differential effects compared to MK-801 in an animal model of anticipatory nausea and vomiting","volume":"35","author":"\u0130lhan \u00c7F","year":"2024","unstructured":"\u0130lhan \u00c7F, \u00dclke E, Urcelay GP, Ki\u015flal S. Propranolol attenuates the establishment of conditioned context aversions: differential effects compared to MK-801 in an animal model of anticipatory nausea and vomiting. Behav Pharmacol. 2024, 35:293-302. 10.1097\/FBP.0000000000000779","journal-title":"Behav Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2409646","article-title":"Routine Beta-Blockers in Secondary Prevention - Approaching Retirement?","volume":"391","author":"Jernberg T","year":"2024","unstructured":"Jernberg T. Routine Beta-Blockers in Secondary Prevention - Approaching Retirement?. N Engl J Med. 2024, 391:1356-7. 10.1056\/NEJMe2409646","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.135146","article-title":"Spatiotemporal dynamics of reactive oxygen species and its effect on beta-blockers' degradation in aquatic plants' rhizosphere","volume":"476","author":"Ji H","year":"2024","unstructured":"Ji H, Li J, Gang D, Yu H, Jia H, Hu C, Qu J. Spatiotemporal dynamics of reactive oxygen species and its effect on beta-blockers' degradation in aquatic plants' rhizosphere. J Hazard Mater. 2024, 476:135146. 10.1016\/j.jhazmat.2024.135146","journal-title":"J Hazard Mater"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph21070910","article-title":"Mental Health Applications of Generative AI and Large Language Modeling in the United States","volume":"21","author":"Banerjee S","year":"2024","unstructured":"Banerjee S, Dunn P, Conard S, Ali A. Mental Health Applications of Generative AI and Large Language Modeling in the United States. Int J Environ Res Public Health. 2024, 21:","journal-title":"Int J Environ Res Public Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16402","article-title":"Comprehensive comparative effectiveness and safety of first-line \u03b2-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study","volume":"77","author":"Chan You S","year":"2021","unstructured":"Chan You S, Krumholz HM, Suchard MA, et al.. Comprehensive comparative effectiveness and safety of first-line \u03b2-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study. Hypertension. 2021, 77:1528-38. 10.1161\/HYPERTENSIONAHA.120.16402","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-024-01221-4","article-title":"Protective effects of \u03b2-blockers on bone in older adults with dementia","volume":"115","author":"Khuc K","year":"2024","unstructured":"Khuc K, des Bordes J, Ogunwale A, et al.. Protective effects of \u03b2-blockers on bone in older adults with dementia. Calcif Tissue Int. 2024, 115:14-22. 10.1007\/s00223-024-01221-4","journal-title":"Calcif Tissue Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2406095","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"391","author":"Komamura K","year":"2024","unstructured":"Komamura K, Kobayashi K, Iwase M. Beta-blockers after myocardial infarction and preserved ejection fraction. N Engl J Med. 2024, 391:94-5. 10.1056\/NEJMc2406095","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-024-03629-0","article-title":"Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry","volume":"19","author":"Lam SH","year":"2024","unstructured":"Lam SH, Romiti GF, Olshansky B, Chao TF, Huisman MV, Lip GY. Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry. Intern Emerg Med. 2024, 19:1369-78. 10.1007\/s11739-024-03629-0","journal-title":"Intern Emerg Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2024.05.024","article-title":"Among patients with acute myocardial infarction who had undergone coronary angiography and with preserved left ventricular ejection fraction, does long-term beta-blocker therapy lower the risk of death or recurrent myocardial infarction? (Article in French)","volume":"45","author":"Lanthier L","year":"2024","unstructured":"Lanthier L, Plourde M\u00c9, Cauchon M. Among patients with acute myocardial infarction who had undergone coronary angiography and with preserved left ventricular ejection fraction, does long-term beta-blocker therapy lower the risk of death or recurrent myocardial infarction? (Article in French). Rev Med Interne. 2024, 45:453-4. 10.1016\/j.revmed.2024.05.024","journal-title":"Rev Med Interne"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1113\/JP285720","article-title":"Metabolomics of repetitive myocardial stunning in chronic multivessel coronary artery stenosis: effect of non-selective and selective \u03b21-receptor blockers","volume":"602","author":"Le DE","year":"2024","unstructured":"Le DE, Alkayed NJ, Cao Z, Chattergoon NN, Garcia-Jaramillo M, Thornburg K, Kaul S. Metabolomics of repetitive myocardial stunning in chronic multivessel coronary artery stenosis: effect of non-selective and selective \u03b21-receptor blockers. J Physiol. 2024, 602:3423-48. 10.1113\/JP285720","journal-title":"J Physiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.135753","article-title":"Development and validation of an imprinted polymer based DGT for monitoring \u03b2-blocker drugs in wastewater surveillance","volume":"479","author":"Li Y","year":"2024","unstructured":"Li Y, Wu M, Yin X, et al.. Development and validation of an imprinted polymer based DGT for monitoring \u03b2-blocker drugs in wastewater surveillance. J Hazard Mater. 2024, 479:135753. 10.1016\/j.jhazmat.2024.135753","journal-title":"J Hazard Mater"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001571","article-title":"Propranolol alleviates cardiac injury after acute catecholamine infusion through p38-MAPK pathways","volume":"84","author":"Liu TH","year":"2024","unstructured":"Liu TH, Hsieh RJ, Chen HH, Kuo TJ, Lee JC, Lu WH. Propranolol alleviates cardiac injury after acute catecholamine infusion through p38-MAPK pathways. J Cardiovasc Pharmacol. 2024, 84:110-17. 10.1097\/FJC.0000000000001571","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001895","article-title":"High-dose propranolol for severe and chronic aggression in autism spectrum disorder: a pilot, double-blind, placebo-controlled, randomized crossover study","volume":"44","author":"London EB","year":"2024","unstructured":"London EB, Zimmerman-Bier BL, Yoo JH, Gaffney JW. High-dose propranolol for severe and chronic aggression in autism spectrum disorder: a pilot, double-blind, placebo-controlled, randomized crossover study. J Clin Psychopharmacol. 2024, 44:462-7. 10.1097\/JCP.0000000000001895","journal-title":"J Clin Psychopharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.09.009","article-title":"The role of the new \u03b2-blockers in treating cardiovascular disease","volume":"18","author":"Weber MA","year":"2005","unstructured":"Weber MA. The role of the new \u03b2-blockers in treating cardiovascular disease. Am J Hypertens. 2005, 18:169-76. 10.1016\/j.amjhyper.2005.09.009","journal-title":"Am J Hypertens"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.067","article-title":"The evolution of \u03b2-blockers in coronary artery disease and heart failure","volume":"74","author":"Joseph P","unstructured":"Joseph P,Swedberg K, Leong DP, Yusuf S. The evolution of \u03b2-blockers in coronary artery disease and heart failure. J Am Coll Cardiol. 15, 74:672-82. 10.1016\/j.jacc.2019.04.067","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2362817","article-title":"An overview of the efficacy and safety of \u03b2(2)-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease","volume":"23","author":"Matera MG","year":"2024","unstructured":"Matera MG, Rogliani P, Calzetta L, Cazzola M. An overview of the efficacy and safety of \u03b2(2)-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary disease. Expert Opin Drug Saf. 2024, 23:833-44. 10.1080\/14740338.2024.2362817","journal-title":"Expert Opin Drug Saf"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.068069","article-title":"Letter by Cardinale et al regarding article, \"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE trial\"","volume":"149","author":"Cardinale D","year":"2024","unstructured":"Cardinale D, Lyon AR, L\u00f3pez-Fern\u00e1ndez T. Letter by Cardinale et al regarding article, \"Multicenter, prospective, randomized controlled trial of high-sensitivity cardiac troponin I-guided combination angiotensin receptor blockade and beta-blocker therapy to prevent anthracycline cardiotoxicity: the Cardiac CARE trial\". Circulation. 2024, 149:e1219-20. 10.1161\/CIRCULATIONAHA.123.068069","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313449-efficacy-of-different-beta-blockers-in-reducing-mortality-in-heart-failure-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T18:45:14Z","timestamp":1732214714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313449-efficacy-of-different-beta-blockers-in-reducing-mortality-in-heart-failure-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.74171","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}